Colgate-Palmolive (NYSE:CL) Position Boosted by Avidian Wealth Solutions LLC

Avidian Wealth Solutions LLC boosted its position in Colgate-Palmolive (NYSE:CL) by 2.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,202 shares of the company’s stock after buying an additional 219 shares during the quarter. Avidian Wealth Solutions LLC’s holdings in Colgate-Palmolive were worth $733,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of CL. OFI Invest Asset Management acquired a new position in Colgate-Palmolive in the third quarter valued at approximately $25,000. Avion Wealth increased its position in Colgate-Palmolive by 78.1% in the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after buying an additional 175 shares during the period. McGlone Suttner Wealth Management Inc. bought a new stake in Colgate-Palmolive in the fourth quarter valued at $34,000. Kayne Anderson Rudnick Investment Management LLC boosted its holdings in shares of Colgate-Palmolive by 142.0% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after acquiring an additional 291 shares during the period. Finally, West Branch Capital LLC grew its position in shares of Colgate-Palmolive by 24.0% during the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after acquiring an additional 132 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the topic of a number of research analyst reports. StockNews.com lowered Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a report on Thursday, January 18th. Royal Bank of Canada lifted their price objective on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a research note on Monday, April 29th. Citigroup increased their target price on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, April 16th. Finally, The Goldman Sachs Group started coverage on Colgate-Palmolive in a report on Friday, March 1st. They issued a “buy” rating and a $93.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $91.44.

Colgate-Palmolive Trading Up 0.1 %

Colgate-Palmolive stock traded up $0.06 during mid-day trading on Monday, hitting $92.94. The stock had a trading volume of 1,453,648 shares, compared to its average volume of 4,653,061. The stock has a market capitalization of $76.25 billion, a PE ratio of 29.39, a P/E/G ratio of 3.43 and a beta of 0.40. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $93.25. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21. The stock has a 50-day simple moving average of $88.35 and a two-hundred day simple moving average of $82.35.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. The firm had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.73 EPS. As a group, sell-side analysts forecast that Colgate-Palmolive will post 3.52 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a $0.50 dividend. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.15%. Colgate-Palmolive’s payout ratio is 63.29%.

Insider Activity at Colgate-Palmolive

In other news, CEO Noel R. Wallace sold 69,948 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the sale, the chief executive officer now owns 286,881 shares of the company’s stock, valued at $24,161,117.82. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 29,772 shares of the company’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $84.06, for a total transaction of $2,502,634.32. Following the sale, the chief executive officer now directly owns 301,343 shares of the company’s stock, valued at $25,330,892.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Noel R. Wallace sold 69,948 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total value of $5,891,020.56. Following the completion of the sale, the chief executive officer now directly owns 286,881 shares of the company’s stock, valued at $24,161,117.82. The disclosure for this sale can be found here. Insiders sold a total of 159,048 shares of company stock worth $13,336,846 in the last quarter. Corporate insiders own 0.37% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.